Strategic Partnership: New Frontier in Biotech and Fintech Convergence

Sonnet BioTherapeutics Merges to Launch Hyperliquid Strategies

In a groundbreaking move, Sonnet BioTherapeutics has announced its merger with Rorschach I LLC to form Hyperliquid Strategies Inc., a publicly traded company that will manage one of the largest public HYPE token reserves.

Source: crypto-economy.com